Position in HROW
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,035,780
+$1,133,110 QoQ
Shares Held
86,097
+121.7% QoQ
Ownership
0.230%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 32%
Shared 0%
None 68%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $63,112,823 across 13 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
765,543 | $40,114,453 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
443,647 | $7,679,529 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
216,960 | $5,339,385 | |
| 4 | EBS |
Emergent BioSolutions Inc.
|
329,060 | $2,757,522 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
227,579 | $1,802,425 | |
| 6 | ZTS |
Zoetis Inc.
|
22,499 | $1,616,778 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,880 | $1,560,470 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,763 | $635,690 |
All Filings in HROW
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,035,780 | 86,097 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,902,670 | 38,830 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $1,439,411 | 47,132 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $226,462 | 6,750 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,143,737 | 47,681 | Shares | Sole | 2024-11-13 | |
| 2021-06-30 | $6,893 | 742 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $169,600 | 25,126 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $8,026 | 1,170 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,045 | 366 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||